Research Article
Tai Chi for Essential Hypertension
Table 1
Characteristics and methodological quality of included studies.
| Study ID | Sample | Diagnosis standard | Intervention | Control | Course | Outcome measure |
| Wei et al. 2003 [25] | 46 | Unclear | 24-type Tai Chi | routine care | 12 m | BP | Han et al. 2010 [26] | 60 | 1999 WHO-ISH GMH | 24-type Tai Chi | routine care | 60 m | BP | Wang et al. 2011 [27] | 30 | CGMH-2005 | 24-type Tai Chi | routine care | 12 w | BP | Tang 2009 [28] | 32 | 1999 WHO-ISH GMH | Tai Chi + control | cilazapril (25 mg qd) | 6 m | BP | Chen et al. 2011 [29] | 441 | CGMH-2005 | Tai Chi | routine care | 24 m | BP | Mao and Sha 2006 [30] | 62 | CGMH-1999 | 24-type Tai Chi | routine care | 8 w | BP | Yi et al. 1990 [31] | 20 | Unclear | Tai Chi | reserpine (4 mg tid), or compound rutin tablets (20 mg tid) | 18 m | BP | Chen 2011 [32] | 61 | CGMH-2005 | Tai Chi | routine care | 12 m | BP | He et al. 2011 [33] | 49 | CGMH-2005 | 24-type Tai Chi, 48-type Tai Chi, and Yang-type Tai Chi | routine care | 20 w | BP | Lo et al. 2012 [34] | 58 | Unclear | Yang-type Tai Chi | routine care | 8 w | BP | Wang 2007 [35] | 46 | Unclear | 24-type Tai Chi | routine care | 8 m | BP | Luo 2006 [36] | 84 | 1999 WHO-ISH GMH | 24-type Tai Chi + control | cilazapril (2.5–5.0 mg qd) | 6 m | BP | Wang et al. 2007 [37] | 84 | 1999 WHO-ISH GMH | 48-type Tai Chi | routine care | 6 m | BP | Zhou 2007 [38] | 120 | JNC-7 | 24-type Tai Chi | routine care | 12 w | BP | Chen and Lv 2006 [39] | 40 | CGMH-2005 | Chen-type Tai Chi + control | nifedipine (50–100 mg qd) | 10 w | BP | Song and Yu 2011 [40] | 50 | Unclear | 12-type Tai Chi | routine care | 2 m | BP | Wang et al. 2011 [41] | 60 | Unclear | Tai Chi | routine care | 16 w | BP | Lee 2004 [42] | 28 | JNC-6 | Tai Chi | routine care | 6 w | BP |
|
|
m: month; w: week.
|